glp 1 and kidney transplant Role of GLP-1 Agonists & SGLT-2 Inhibitors in Care Preserving Kidney Function in Patients

Each weekly dose from 0.25mg2.4mg draws less than 0.5mL, keeping injection volume comfortable

Novo Nordisk launches D2C platform, drops price of Wegovy for cash-pay patients: The move could start a marketing showdownand possible price warbetween Novo and Lilly

Compounded HRT becomes clinically relevant in specific circumstances: When FDA-approved products are unavailable

In the 12 months after an index event, 1.5% of patients with nonfatal MI and 0.5% with nonfatal stroke initiated a GLP-1, the two most common being semaglutide (Wegovy, Novo Nordisk) and liraglutide, followed by dulaglutide (Trulicity, Eli Lilly)